证券日报网讯百联股份11月24日在互动平台回答投资者提问时表示，公司高度重视投资者回报，自2016 年度至今连续九年实施稳健的分红政策，持续以现金分红回报广大投资者，近三年累计现金分红9.01亿 元。公司上市以来经历多轮吸收合并，不同的第三方交易软件对于融资金额的计算口径不同。请投资者 以公司信息披露为准。 （文章来源：证券日报） ...

董秘回答(神州信息SZ000555)： 尊敬的投资者，您好！公司前三季度营收稳步增长，期间实现营业收入86.73 亿元，同比增长29.84%， 现金流随业务发展显著改善，公司资金储备较为充实，能够支撑公司各项业务有序开展。未来，公司将 持续保持稳健经营，更加重视投资者回报，加强投资者信心，树立良好资本市场形象。感谢您对公司的 关注！查看更多董秘问答>> 免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确 性，内容仅供参考。 投资者提问： 董秘您好！公司最新财报显示经营性现金流净额同比大幅增长，请问现金流改善的核心原因是什么？目 前公司货币资金储备是否充足，能否支撑后续扩产、研发投入与潜在并购需求？公司是否有优化分红政 策的计划，未来分红比例能否进一步提升，以回馈广大投资者？健康的现金流状况与稳定的分红预期， 能否增强市场对公司发展的信心，推动公司估值向合理水平回归？ ...

证券日报网讯新国都（300130）11月18日在互动平台回答投资者提问时表示，公司自上市以来，累计开 展16次分红，近两年积极响应政策号召实施一年多次分红，切实践行了对投资者的回报。公司将继续努 力做好经营和管理，促进公司高质量发展，力争以良好的经营业绩来得到市场的认可，从而提升公司的 投资价值。公司也将继续加强与投资者的沟通，增强投资者对公司的了解，以获得广大投资者的认可。 ...

截至2025年11月17日收盘，永利股份(300230)报收于5.19元，下跌0.76%，换手率2.76%，成交量17.37万 手，成交额8966.29万元。 董秘最新回复 投资者： 公司股价多年不涨，是内部出现了什么问题？如果没有，请问公司有做出什么努力回报投资 者呢？ 董秘： 您好，公司生产经营一切正常，2025年前三季度公司实现营收17.75亿元，同比增长8.66%。公 司股价受二级市场整体表现、宏观政策、行业周期、资本市场环境、投资者情绪等多重因素影响。公司 管理层坚定地看好公司未来发展，始终把企业经营作为价值管理的核心，未来将继续努力提升经营管理 水平，深耕主营业务，力争实现经营业绩稳定增长，为股东创造长期价值；同时公司也将一如既往地重 视与投资者的交流，强化投资者回报，积极向投资者传递公司价值。感谢您对公司的关注！ 当日关注点 来自交易信息汇总：11月17日主力资金净流入1258.32万元，呈现明显吸筹迹象。 交易信息汇总资金流向 11月17日主力资金净流入1258.32万元；游资资金净流出977.86万元；散户资金净流出280.47万元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算 ...

Core Points - The company announced a profit distribution plan for the first three quarters of 2025 to enhance shareholder returns and respond to regulatory guidance [1][2] - The net profit attributable to shareholders for the first three quarters of 2025 was approximately 1.06 billion yuan, with the parent company achieving a net profit of about 618 million yuan [1] - The total distributable profit for the parent company as of September 30, 2025, was approximately 3.82 billion yuan, while the consolidated distributable profit was about 7.52 billion yuan [1] Profit Distribution Plan - The profit distribution plan involves a cash dividend of 3.00 yuan per 10 shares, amounting to a total cash dividend of approximately 358.48 million yuan [2] - The distribution will not include capital reserve transfers to increase share capital or stock dividends, with remaining undistributed profits reserved for future distribution [2] - The company emphasized its stable profitability and ample cash flow, stating that the profit distribution plan will enhance investor returns and maintain the stability and sustainability of its dividend policy [2]

Group 1 - The company emphasizes its commitment to investor returns and has maintained a cash dividend policy since its listing, with a total dividend amount of 48.4984 million yuan, accounting for 40.65% of the net profit during the same period [1] - In the future, the company plans to develop a reasonable profit distribution plan based on actual operating conditions, industry development stages, and funding needs to effectively protect shareholder rights [1]

Core Viewpoint - The company, Lifesun Pharmaceutical (002393), is focusing on balancing shareholder returns with business development, emphasizing the importance of sharing growth benefits with investors [2]. Group 1: Stock Performance - As of November 7, 2025, Lifesun Pharmaceutical's stock closed at 21.67 yuan, with a slight increase of 0.28% [1]. - The trading volume was 24,800 shares, resulting in a transaction amount of 53.79 million yuan [1]. Group 2: Investor Relations - An investor expressed concerns regarding the company's dividend policy, suggesting that the company should distribute more dividends to attract long-term investors like social security funds and insurance capital [2]. - The company’s secretary acknowledged the investor's feedback, stating that the current dividend policy aims to balance business growth and shareholder returns, taking into account industry characteristics, profitability, and cash flow [2]. Group 3: Market Sentiment - On November 7, there was a net outflow of 1.58 million yuan from institutional investors, while retail investors saw a net inflow of 2.78 million yuan, indicating a divergence in short-term trading sentiment [3]. - Retail investors experienced a net outflow of 1.20 million yuan on the same day [3].

Core Viewpoint - The active equity funds are undergoing a transformation from focusing on scale to controlling scale, emphasizing investor returns over sheer size [1][5][7] Group 1: Fund Size Control - Multiple funds have implemented measures to limit their scale, such as setting upper limits, restricting purchases, and closing fundraising early [2][3] - Notable funds managed by well-known managers have reached their fundraising caps within days, indicating a trend towards controlled growth [2][3] - As of November 7, 39 out of 43 newly established equity funds with sizes over 1 billion yuan had fundraising scales below 30 billion yuan [2] Group 2: Historical Lessons - The industry has learned from past experiences where large funds underperformed, with over 85% of funds with net values below 1 yuan established between 2020 and 2022 [5][6] - A significant number of large funds launched in 2020 have seen substantial declines in net value despite short-term gains, highlighting the risks of scale without performance [6][5] Group 3: Optimal Fund Size - The optimal size for active equity funds is suggested to be between 3 billion and 5 billion yuan, balancing operational stability and flexibility in trading [8][7] - Factors such as market liquidity and the number of investable assets are critical in determining the appropriate scale for a fund [7][8] - The industry is shifting towards a model where fund size is aligned with investment strategies, promoting a healthier ecosystem focused on performance rather than just scale [8][7]

Group 1 - The company emphasizes the importance of market value management and investor returns [2] - The company commits to timely information disclosure regarding significant information related to stock price fluctuations [2]

Core Insights - The A-share market has shown steady growth in the first three quarters of 2025, with total operating revenue reaching approximately 53.5 trillion yuan, a year-on-year increase of 1.36%, and net profit attributable to shareholders reaching 4.7 trillion yuan, up 5.5% year-on-year [2][4] Group 1: Financial Performance - In the first three quarters of 2025, the Shanghai Stock Exchange companies achieved total operating revenue of 37.58 trillion yuan, with a net profit of 3.79 trillion yuan, reflecting a year-on-year growth of 4.5% [4] - The Shenzhen Stock Exchange companies reported total operating revenue of 15.72 trillion yuan, with net profit of 903.02 billion yuan, marking a year-on-year increase of 9.69% [4] - The Beijing Stock Exchange companies generated total operating revenue of 145.07 billion yuan and net profit of 9.20 billion yuan [4] Group 2: R&D Investment - A-share listed companies collectively invested 1.45 trillion yuan in R&D, accounting for approximately 2.7% of their operating revenue [3][8] - Notably, 1,596 companies reported R&D expenses exceeding 100 million yuan, with 63 companies spending over 1 billion yuan [8] Group 3: Dividend and Buyback Trends - Over 1,000 companies announced dividend plans in 2025, with total cash dividends amounting to 734.9 billion yuan, reflecting a significant increase in shareholder returns [3][9] - The frequency of share buybacks has also risen, with 1,195 companies announcing 1,525 buyback plans, of which 899 have been completed [9] Group 4: Sector Performance - The technology innovation sector, particularly the ChiNext board, has shown remarkable growth, with ChiNext companies achieving operating revenue of 3.25 trillion yuan and net profit of 244.66 billion yuan, both growing over 10% year-on-year [5][6] - Major companies like China Petroleum, China Petrochemical, and China State Construction led in revenue, with respective revenues of 2.17 trillion yuan, 2.11 trillion yuan, and 1.56 trillion yuan [6] Group 5: High Growth Companies - Several companies exhibited extraordinary revenue growth, with Haichuang Pharmaceutical and others reporting revenue increases of over 10 times [7] - A total of 60 companies saw net profit growth exceeding 10 times, with 3027 companies reporting positive net profit growth [7]